Article · Wikipedia archive · Last revised Jun 23, 2026

TFMBOX

TFMBOX is a putative serotonergic psychedelic of the phenethylamine and benzoxepin ("BOX") families. It is the cyclized phenethylamine analogue of DOTFM and 2C-TFM in which the α carbon has been connected to the 2-methoxy group via an ethyl chain to form a benzoxepin ring system.

Last revised
Jun 23, 2026
Read time
≈ 2 min
Length
446 w
Citations
16
Source
Wikipedia ↗
TFMBOX
Clinical data
Other names"Compound 5c"
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
Identifiers
  • 7-methoxy-8-(trifluoromethyl)-2,3,4,5-tetrahydro-1-benzoxepin-4-amine
CAS Number
Chemical and physical data
FormulaC12H14F3NO2
Molar mass261.244 g·mol−1
3D model (JSmol)
  • COc1cc2CC(N)CCOc2cc1C(F)(F)F
  • InChI=1S/C12H14F3NO2/c1-17-11-5-7-4-8(16)2-3-18-10(7)6-9(11)12(13,14)15/h5-6,8H,2-4,16H2,1H3
  • Key:NAOXZRLWFAOHAP-UHFFFAOYSA-N

TFMBOX is a putative serotonergic psychedelic of the phenethylamine and benzoxepin ("BOX") families.123 It is the cyclized phenethylamine analogue of DOTFM and 2C-TFM in which the α carbon has been connected to the 2-methoxy group via an ethyl chain to form a benzoxepin ring system.12

Interactions

Pharmacology

Pharmacodynamics

The drug was assessed at and showed affinity for the serotonin 5-HT2A and 5-HT1A receptors, with Ki values of 340 nM and 1,300 nM, respectively.2 Its affinity for the serotonin 5-HT2A receptor was about 15-fold lower than that of DOB and DOI, whereas its affinity for the serotonin 5-HT1A receptor was the same as that of DOI and was about half that of DOB.2 TFMBOX also very weakly inhibited the reuptake of serotonin (IC50Tooltip half-maximal inhibitory concentration = 9,900 nM), but did not affect dopamine or norepinephrine reuptake (IC50 = >50,000–100,000 nM).2 The drug fully substituted for LSD in rodent drug discrimination tests, albeit with about one-third of the potency of DOB and 2C-B.2

Chemistry

Analogues

Other "BOX" drugs that have been assessed include BOX (the cyclized analogue of 2C-H and DOH), BBOX (the cyclized analogue of 2C-B and DOB), and IBOX (the cyclized analogue of 2C-I and DOI).23 However, BBOX and IBOX only partially substituted for LSD in drug discrimination tests.234

Chemical structures of BOX compounds
  • BOX​​​
    BOX
  • TFMBOX​​​
    TFMBOX
  • BBOX​​​
    BBOX
  • IBOX​​​
    IBOX

History

TFMBOX was first described in the scientific literature by Nicholas Cozzi, a student of David E. Nichols, by 1994.23

See also

See also

References

References

  1. Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. pp. 852–853. ISBN 978-3-03788-700-4. OCLC 858805226. Retrieved 31 January 2025.
  2. Monte AP, Marona-Lewicka D, Cozzi NV, Nelson DL, Nichols DE (1995). "Conformationally Restricted Tetrahydro-1-Benzoxepin Analogs of Hallucinogenic Phenethylamines". Medicinal Chemistry Research. 5 (651–663).
  3. Cozzi NV (1994). Pharmacological studies of some psychoactive phenylalkylamines: Entactogens, hallucinogens, and anorectics (Ph.D. thesis). University of Wisconsin, Madison. Retrieved 15 April 2025.
  4. Monte AP (August 1995). Structure-activity relationships of hallucinogens: Design, synthesis, and pharmacological evaluation of a series of conformationally restricted phenethylamines (Ph.D. thesis). Purdue University. Retrieved 15 April 2025.
External links